Old injuries that flare — what 'chronic' really means at the tissue level
7 min read · Uplevel editorial
The ankle you sprained at twenty-two still gives you a signal when rain is coming. Not dramatic — just a low-grade tightness, a slight reluctance in the lateral ligaments, a vague awareness that something there is different from the other side. The lower back that went out three years ago tightens up every time you're in a middle seat for more than two hours. The shoulder from the old climbing fall reappears — specifically, clearly, unmistakably — in the weeks when work is overwhelming and sleep is short. You've learned to live around these things. You've stopped calling them injuries. They're just yours now, a personal catalog of soft tissue memory that most providers stopped asking about once the acute phase resolved.
The word "chronic" is doing a lot of unexamined work in the phrase "chronic pain." It implies permanence, and permanence implies there's nothing more to understand — just manage and adapt. But at the tissue level, chronic doesn't mean permanent. It means a condition that wasn't fully resolved and has been maintained in an incomplete state. That distinction matters, because it changes whether you're looking at a fixed ceiling or an unfinished process.
Three things are usually happening simultaneously in an old injury that keeps flaring. The first is structural: the tissue healed incompletely. Scar tissue formed where organized collagen should have been. Scar tissue is less elastic than the original tissue, less vascularized, and less capable of managing the same mechanical loads. It's functional enough — most of the time you don't notice it — but it's more vulnerable to overload, and overload produces pain faster than it would in healthy tissue. The ankle that sprained badly at twenty-two may have healed to ninety percent of its original ligament integrity. That's a lot. It's also not the same as the other ankle, and in high-demand moments, the difference shows.
The second thing happening is a compensation pattern. The body is exquisitely good at protecting injured tissue by redistributing load to uninjured tissue. After an ankle sprain, you unconsciously unload that ankle and let the knee and hip absorb more. After a shoulder injury, the muscles around the injury site tighten to splint it, and the mechanics of how you reach and lift shift to protect the vulnerable area. These patterns are adaptive at the time and maladaptive over years. The muscles that have been compensating start to break down from the extra load. The joints that have been moving in modified patterns accumulate wear from the altered mechanics. The original injury site, protected from loading, doesn't get the mechanical stimulus it needs for full tissue remodeling. You end up with a cascade: one injury that healed at ninety percent, and a surrounding system that has quietly been paying the tax ever since.
The third thing is the nervous system's contribution, which is often the most underappreciated. Pain isn't simply a signal from damaged tissue — it's an output of the nervous system, a prediction about threat based on available information. After a significant injury, the nervous system files that region as a threat. The protective response — heightened sensitivity, increased pain signaling from that area — was appropriate in the acute phase. But nervous systems are conservative. They tend to leave that protective setting on longer than the tissue damage warrants, especially if the injury was severe, scary, or undertreated. Researchers call the persistent sensitized pattern a "neurotag" — a learned neural representation that predicts danger in a specific tissue area and keeps predicting it even after the tissue itself has stabilized. This is why the old shoulder reappears when stress climbs. The nervous system isn't detecting new damage; it's upregulating an existing threat prediction in response to reduced resilience. The shoulder becomes the body's preferred alarm site because it has an established alarm pathway.
These three mechanisms — incomplete structural healing, compensatory movement patterns, and sensitized nervous system predictions — interact. Scar tissue is more pain-sensitive than healthy tissue, which reinforces the nervous system's threat assessment. Compensation patterns create secondary damage that adds real tissue signals to the sensitized system. The sensitized system increases protective muscle guarding, which restricts movement and reduces the loading stimulus the tissue needs to remodel. The loop can sustain itself for years without any new injury event.
What breaks the loop is not a single intervention. It's a coordinated approach that addresses all three mechanisms. Targeted rehabilitation that progressively reloads the injured tissue challenges both the structural scar and the nervous system's threat prediction simultaneously — controlled loading in the context of safety signals gradually revises the neural representation. Addressing the compensation pattern, which usually requires a good movement assessment and specific work on the muscles that have been overprotected, takes load off the secondary breakdown sites and restores more normal mechanics to the whole kinetic chain. Nervous system regulation — which includes adequate sleep, stress management, and graded exposure to the movement patterns that have been avoided — is not optional here, particularly for the patient whose old injuries respond strongly to life stress.
This is where peptides like BPC-157 and TB-500 potentially enter the conversation — as a signal nudge to tissue that has settled into chronic incomplete healing. The research interest in BPC-157 centers on angiogenesis: its role in prompting injured tissue to develop new blood vessel infrastructure, which is necessary for any meaningful tissue remodeling to occur. TB-500's researched mechanism involves cell migration to injury sites and anti-inflammatory modulation. Scar tissue is poorly vascularized, which is part of why it doesn't remodel spontaneously — it lacks the delivery system for the cells and growth factors that remodeling requires. The hypothesis underlying the use of these peptides in chronic injury contexts is that providing an angiogenic and cell migration signal to stalled tissue might help restart a biological process that quietly stopped years ago.
It's important to be honest about the evidence here. Animal models support the mechanism. Human clinical trials are limited. Practitioners working in regenerative and sports medicine contexts report clinical observations that are consistent with the mechanism, but that's a different level of evidence than controlled human trials. Your prescribing provider would be approaching this as a research-informed conversation, not a proven protocol — and that conversation should happen in the context of your full injury history, your current rehab status, and a realistic understanding of what a signal nudge can and can't do.
What it can't do is replace the work. If the compensation pattern hasn't been identified and addressed, the original injury site keeps getting protected from the loading it needs. If the nervous system sensitization hasn't been worked with, the pain response stays hypervigilant regardless of what the tissue is doing. Sleep and systemic recovery quality matter for tissue remodeling at a cellular level that peptides can't override. The structural, behavioral, and neural components of a chronic injury all need attention. Peptides, if they have a role, have it as one piece of a comprehensive approach — a way to support the regenerative environment that the rest of the work is trying to create.
The lifelong injury — the ankle, the back, the shoulder that comes and goes — is rarely as fixed as it feels on the days it's quiet. It's tissue in an incomplete state, maintained there by a set of biological and neurological mechanisms that, once you understand them, start to look less like permanent conditions and more like unfinished conversations between the body and an injury that never got a proper resolution. The conversation is still open. The tissue is still capable of receiving signal. The question worth asking, with honest expectations and good clinical support, is whether the right signals have actually been sent.